Abridge

Product & Competitive Intelligence

Ambient AI that turns clinician-patient conversations into billable EHR notes.

Company Overview

Abridge is a clinical AI company that generates structured, billable medical notes from ambient patient-clinician conversations and writes them into the EHR. Serving customers across academic medical centers (Mayo Clinic, Johns Hopkins), integrated health systems (Kaiser, UPMC), and specialty networks (Sloan Kettering).

Latest Intel

Zeitgeist tracks private signals to determine where the company is heading and what it means competitively.

No Signals Yet

View All The Latest Signals

What They're Building

The company's public product roadmap & what they're committed to building.

Specialty Models:

Dedicated models for hematology-oncology, gastroenterology, and surgery targeting GA by end of 2025.

Inpatient and Orders:

Expansion beyond outpatient visits into inpatient documentation and Epic order queuing for meds, labs, and imaging.

Revenue Cycle:

Prior authorization and RCM workflows built with Availity and Highmark Health.

Clinical Decision Support:

Point-of-care prompts sourced from NEJM, JAMA, and Wolters Kluwer UpToDate.

Contextual Reasoning Engine:

Proprietary engine pairing ASR with clinical LLMs, with Linked Evidence mapping every summary line back to source audio.

Competitive Landscape & Moat

Proprietary clinician-labeled conversation data at massive scale (80M+ annual encounters) plus deep Epic workflow integration that competitors cannot replicate without equivalent health system penetration.

Direct Competitors

Nuance DAX Copilot:

Microsoft-backed incumbent with the largest install base, but weaker reputation for rapid iteration and specialty depth.

Suki AI:

Cheaper and more EHR-agnostic, aimed at smaller practices rather than enterprise health systems.

Nabla:

Europe-born competitor strong on Meditech shops and clinician UX, but thinner on US enterprise Epic deployments.

Founding Team

Funding History